In a busy second quarter of 2020, the GvHD Hub continued with the editorial theme of novel therapies for the treatment of GvHD. In May, the GvHD Hub provided virtual coverage of the European Society for Blood and Marrow Transplantation (EBMT) webinars, discussing pathophysiology, prophylaxis, and management of acute and chronic GvHD, as well as novel therapeutic strategies. In June, the GvHD Hub provided extensive live coverage of the virtual American Society of Clinical Oncology (ASCO) Annual Meeting and the virtual European Hematology Association (EHA) Annual Congress (EHA25) via the Twitter channel. We also interviewed experts who took part in these exciting congresses and published summaries of key sessions.
The GvHD Hub
is a global online resource guided by an international Steering Committee of world experts in graft-versus-host disease (GvHD). The GvHD Hub is run in collaboration with the European LeukemiaNet. The GvHD Hub is brought to you by Scientific Education Support (SES), who love nothing more than building communities and networks to enhance the level of collective knowledge, using multichannel communications to disseminate medical advances. The GvHD Hub would like to thank the Silver supporter Incyte and Bronze supporter Novartis for their continued support of the initiative.
For more information on the GvHD Hub, please visit www.gvhdhub.com. For media enquiries or to explore collaboration opportunities, please contact: firstname.lastname@example.org
Press release distributed by Pressat on behalf of Scientific Education Support, on Tuesday 21 July, 2020. For more information subscribe and follow https://pressat.co.uk/